Physician profile
Deep Shah
NPI 1447634779
$3,755.11
in general payments reported to CMS, 2019-2025
9 companies · $2,601 in 2025
The $2,601 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2021: $112 · 2023: $224 · 2024: $389 · 2025: $2,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $930 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $929.80 |
| Education | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,100.00 | 2025 | |
| Genzyme Corporation | $758.10 | 2023-2025 | |
| Novo Nordisk INC | $429.12 | 2019 | |
| Incyte Corporation | $112.19 | 2021 | |
| Stryker Corporation | $100.25 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $99.00 | 2024 | |
| Alexion Pharmaceuticals, INC. | $85.00 | 2024 | Soliris |
| Janssen Biotech, INC. | $36.10 | 2025 | Carvykti |
| Medshape, INC. | $35.35 | 2023 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deep Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.